129 related articles for article (PubMed ID: 9182855)
1. Expression of estrogen receptor exon 5 splicing variant (ER E5SV) mRNA in gynaecological cancers.
Fujimoto J; Ichigo S; Hirose R; Hori M; Tamaya T
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):25-30. PubMed ID: 9182855
[TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptor wild type and exon 5 splicing variant mRNAs in normal and endometriotic endometria during the menstrual cycle.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Gynecol Endocrinol; 1997 Feb; 11(1):11-6. PubMed ID: 9086333
[TBL] [Abstract][Full Text] [Related]
3. [Expression of estrogen receptor beta mRNA in endometrial carcinoma and its significance].
Wen H
Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):108-10. PubMed ID: 11783346
[TBL] [Abstract][Full Text] [Related]
4. Expression of sex hormone-binding globulin exon 7 splicing variant mRNA in secondary spreading lesions of gynecological cancers.
Misao R; Iwagaki S; Fujimoto J; Nakanishi Y; Sun WS; Tamaya T
J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):103-9. PubMed ID: 10369407
[TBL] [Abstract][Full Text] [Related]
5. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma.
Mito K; Tamura T; Hosokawa K; Kondo T; Yamamoto T; Honjo H
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):9-16. PubMed ID: 9780024
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma.
Cobellis L; Reis FM; Driul L; Vultaggio G; Ferretti I; Villa E; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):92-5. PubMed ID: 12039098
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
Rice LW; Jazaeri AA; Shupnik MA
Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
[TBL] [Abstract][Full Text] [Related]
8. Presence of alternatively spliced-estrogen receptor mRNA variants in normal human uterine endometrium and endometrial cancer.
Hirata S; Yamada-Mouri N; Nara M; Takizawa M; Ito H; Kato J
Endocr J; 1995 Apr; 42(2):289-93. PubMed ID: 7542977
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor beta exon-deleted variant mRNAs in ovary and uterine endometrium.
Fujimoto J; Sun WS; Misao R; Sakaguchi H; Aoki I; Toyoki H; Tamaya T
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):133-40. PubMed ID: 12710996
[TBL] [Abstract][Full Text] [Related]
10. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas.
Park W; Choi JJ; Hwang ES; Lee JH
Clin Cancer Res; 1996 Dec; 2(12):2029-35. PubMed ID: 9816163
[TBL] [Abstract][Full Text] [Related]
11. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
Chan CM; Dowsett M
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptors and metastatic potential in endometrial cancers.
Fujimoto J; Sakaguchi H; Aoki I; Tamaya T
Eur J Cancer; 2000 Sep; 36 Suppl 4():S33. PubMed ID: 11056308
[TBL] [Abstract][Full Text] [Related]
13. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
14. Novel splicing events of untranslated first exons in human estrogen receptor alpha (ER alpha) gene.
Okuda Y; Hirata S; Watanabe N; Shoda T; Kato J; Hoshi K
Endocr J; 2003 Feb; 50(1):97-104. PubMed ID: 12733715
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptor variants in normal and neoplastic human uterus.
Hu C; Hyder SM; Needleman DS; Baker VV
Mol Cell Endocrinol; 1996 Apr; 118(1-2):173-9. PubMed ID: 8735603
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in human pancreatic cancers by real-time polymerase chain reaction.
Iwao K; Miyoshi Y; Ooka M; Ishikawa O; Ohigashi H; Kasugai T; Egawa C; Noguchi S
Cancer Lett; 2001 Sep; 170(1):91-7. PubMed ID: 11448539
[TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen receptor alpha exon 5 and 7 deletion variant in human breast cancers.
Omoto Y; Iwase H; Iwata H; Hara Y; Toyama T; Ando Y; Kobayashi S
Breast Cancer; 2000 Jan; 7(1):27-31. PubMed ID: 11029767
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of expression of estrogen receptor alpha and beta mRNAs in ovarian cancers.
Fujimoto J; Hirose R; Sakaguchi H; Tamaya T
Oncology; 2000 May; 58(4):334-41. PubMed ID: 10838500
[TBL] [Abstract][Full Text] [Related]
19. Absence of estrogen receptor-beta expression in metastatic ovarian cancer.
Rutherford T; Brown WD; Sapi E; Aschkenazi S; Muñoz A; Mor G
Obstet Gynecol; 2000 Sep; 96(3):417-21. PubMed ID: 10960636
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers.
Fujimoto J; Sakaguchi H; Aoki I; Toyoki H; Tamaya T
Oncology; 2002; 62(3):269-77. PubMed ID: 12065875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
